Achieve outlines Q4 2026 NDA resubmission and 1H 2027 launch plans following $180M financing
Achieve Life Sciences, Inc. · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES · Now $5.30
-23% in 7d after detection
Post-detection moves
1h
—
1d
-0.5%
3d
-12%
7d
-23%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS